** Shares of Chinese medical device maker Meihua
International Medical Technologies Co MHUA.O rise 12.11% to
$29.16
** Co says its subsidiary entered into an agreement with
Qionghai City of Hainan Province to build technology park
project urn:newsml:reuters.com:*:nPn5B7rJca
** Subsidiary co has also entered into an agreement with
Hainan to build MHUA a medical research and development center
in the Hope City
** MHUA's medical R&D center will carry out research and
development of stem cell to human targeted therapies and
rehabilitation training projects
** MHUA gained more than doubled since IPO in February 2022
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))